Caplan A L
J Health Polit Policy Law. 1981 Fall;6(3):488-503. doi: 10.1215/03616878-6-3-488.
This article examines the policy lessons to be learned from the American experience with the End-Stage Renal Disease program. This program was instituted in 1972 as an amendment to the Social Security Act to provide reimbursement for the costs of therapy to those persons suffering from renal failure. The article tries to debunk certain common myths that have arisen concerning the ESRD program, by examining the history and evolution of renal dialysis technology as well as the social policies concerning dialysis pursued in England and Sweden. It argues that while the ESRD program is not a genuine instance of a 'mini' national health insurance program, there are important moral, social, and policy lessons to be learned from this unique effort to provide renal therapies to those Americans in need.
本文探讨了可从美国终末期肾病项目的经验中汲取的政策教训。该项目于1972年作为《社会保障法》的一项修正案设立,旨在为肾衰竭患者的治疗费用提供报销。本文通过考察肾透析技术的历史与发展以及英国和瑞典推行的有关透析的社会政策,试图揭穿围绕终末期肾病项目产生的某些常见谬见。文章认为,虽然终末期肾病项目并非真正意义上的“小型”国家医疗保险项目实例,但从这一为有需要的美国人提供肾脏治疗的独特举措中,仍可汲取重要的道德、社会和政策教训。